查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1604648

心律不整市場：依發生部位、心房、測試設備分類 - 全球預測 2025-2030 年

Arrhythmia Market by Site Of Origin Atrial (Atrial Tachycardia, Premature Atrial Contractions, Sinus Bradycardia), Test Equipment (Electrocardiogram, Holter Monitor) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年心律不整市場規模為60.1億美元，預計2024年將達到64.8億美元，複合年成長率為7.97%，預計2030年將達到102.9億美元。

心律不整是一種以心率不規則為特徵的疾病，由於人口老化和心血管疾病意識的增強，其盛行率不斷增加，因此需要進行徹底的市場研究。心律不整相關產品和服務市場包括診斷工具、心律調節器和心臟去顫器等治療設備以及消融手術。醫療產業需要解決心律不整問題，以降低中風風險並提高生活品質，這對於醫療保健提供者、醫院和外科中心至關重要。最近的見解表明，人工智慧主導的診斷和穿戴式監控設備等技術進步是關鍵的成長要素。這些進步不僅提高了早期檢測和干涉能力，還滿足了消費者對非侵入式健康監測解決方案不斷成長的需求。此外，微創手術技術在治療領域具有潛力，擴大了市場機會。

主要市場統計
基準年[2023] 60.1億美元
預計年份 [2024] 64.8億美元
預測年份 [2030] 102.9億美元
複合年成長率（%） 7.97%

儘管有這些機遇，但仍存在一些挑戰。先進的治療和診斷工具的高昂成本令人望而卻步，凸顯了對具有成本效益的創新的需求。監管障礙和廣泛的臨床試驗要求使市場進入和擴張更加複雜。此外，意識低下，尤其是在新興市場，可能會阻礙市場滲透。透過專注於整合遠端醫療和遠端監控解決方案，創新者有潛力提高可近性、降低成本並改變都市區和農村環境的醫療保健。此外，透過基因檢測和個人化治療的個人化醫療是一個有前途的研究前沿。

儘管心律不整市場有望成長，但也並非沒有挑戰。想要成功的公司必須在創新和承受能力之間取得平衡，同時利用監管環境。當前的市場動態表明，正在轉向利用技術進步的更整合、消費者友好的解決方案，從而導致公司改變其業務策略和研究工作來滿足這些新需求，這將為協調提供堅實的平台。公司應優先考慮策略夥伴關係和研發投資，以有效利用這些機會。

市場動態：揭示快速發展的心律不整市場的關鍵市場洞察

供需的動態交互作用正在改變心律不整市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 人群中心律不整的盛行率不斷增加以及對心律不整監測設備的需求
    • 灌注射頻 (RF) 消融導管裝置的趨勢
    • 關於心律不整的宣傳活動日益增多
  • 市場限制因素
    • 與心律不整治療和設備相關的高成本
  • 市場機會
    • 心律不整設備的技術進步
    • 積極的研究活動開發新的心律不整治療方法
  • 市場挑戰
    • 動態心電圖記錄用於心律不整監測的局限性

波特五力：駕馭心律不整市場的策略工具

波特的五力架構是了解心律不整市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解心律不整市場的外在影響

外部宏觀環境因素在塑造心律不整市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解心律不整市場的競爭狀況

對心律不整市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣心律不整市場供應商的績效評估

FPNV定位矩陣是評估心律不整市場供應商的關鍵工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議繪製心律不整市場的成功之路

心律不整市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 人群中心律不整的盛行率不斷增加以及對心律不整監測設備的需求
      • 灌注射頻 (RF) 消融導管裝置的趨勢
      • 心律不整意識宣傳活動
    • 抑制因素
      • 與心律不整治療和設備相關的高成本
    • 機會
      • 心律不整設備的技術進步
      • 大力研究發展新的心律不整治療方法
    • 任務
      • 動態心電圖記錄在心律不整監測的局限性
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章按心房起源部位分類的心律不整市場

  • 房性心搏過速
  • 心房早搏
  • 心搏過緩心搏過緩
  • 移動心房心律調節器

第7章 心律不整市場（依測試設備）

  • 心電圖
  • 心電圖監測

第8章美洲心律不整市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太地區心律不整市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章 歐洲、中東和非洲心律不整市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • ACS Diagnostics
  • AliveCor, Inc.
  • AtriCure Inc.
  • Biotricity
  • BIOTRONIK, Inc.
  • Boston Scientific Corporation
  • CardioFocus, Inc.
  • CathRx Ltd.
  • Fukuda Denshi
  • GE Healthcare
  • GlaxoSmithKline PLC
  • Hill-Rom Holdings, Inc
  • iRhythm Technologies Inc.
  • Koninklijke Philips NV
  • Medi-Lynx Cardiac Monitoring, LLC
  • Medtronic PLC
  • MicroPort Scientific Corporation
  • Nihon Kohden Corporation
  • Novartis AG
  • OSI Systems, Inc.
  • Sanofi SA
  • SCHILLER
  • Siemens Healthcare GmbH
  • St. Jude Medical, Inc.
Product Code: MRR-A26E0E5742FF

The Arrhythmia Market was valued at USD 6.01 billion in 2023, expected to reach USD 6.48 billion in 2024, and is projected to grow at a CAGR of 7.97%, to USD 10.29 billion by 2030.

Arrhythmia, a condition characterized by irregular heartbeats, necessitates thorough market research due to its rising prevalence, driven by aging populations and increasing awareness of cardiovascular diseases. The market for arrhythmia-related products and services encompasses diagnostic tools, treatment devices like pacemakers and defibrillators, and ablation procedures. The medical industry's necessity to address arrhythmias lies in reducing stroke risk and improving quality of life, making it essential for healthcare providers, hospitals, and surgical centers. Recent insights indicate that technological advances, such as AI-driven diagnostics and wearable monitoring devices, are key growth influencers. These advancements not only improve early detection and intervention capabilities but also cater to the growing consumer demand for non-intrusive health monitoring solutions. Furthermore, the therapeutic sector sees potential in minimally invasive surgical techniques, expanding opportunities within the market.

KEY MARKET STATISTICS
Base Year [2023] USD 6.01 billion
Estimated Year [2024] USD 6.48 billion
Forecast Year [2030] USD 10.29 billion
CAGR (%) 7.97%

Despite these opportunities, several challenges remain. High costs of advanced treatment and diagnostic tools can be prohibitive, underscoring the need for cost-effective innovations. Regulatory hurdles and the extensive clinical trial requirements further complicate market entry and expansion. Also, limited awareness, especially in developing regions, may hinder market penetration. Innovators can focus on the integration of telemedicine with remote monitoring solutions to increase accessibility and reduce costs, potentially transforming care in both urban and rural settings. Additionally, personalized medicine, aided by genetic testing and individualized treatment, represents a promising research frontier.

The arrhythmia market, though poised for growth, is not without its challenges. Companies aiming for success need to balance innovation with affordability while navigating regulatory landscapes. Current market dynamics suggest a shift towards more integrated, consumer-friendly solutions that leverage technological advancements, thus providing a robust platform for organizations to align their business strategies and research efforts to meet these emerging demands. Firms should prioritize strategic partnerships and R&D investments to harness these opportunities effectively.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Arrhythmia Market

The Arrhythmia Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of arrhythmia among population and need for arrhythmia monitoring devices
    • Trend of irrigated radiofrequency (RF) ablation catheter devices
    • Rising awareness campaigns for arrhythmia
  • Market Restraints
    • High-cost associated with arrhythmia treatment and devices
  • Market Opportunities
    • Technological advancements in arrhythmia devices
    • Robust research activities to develop new arrhythmia treatments
  • Market Challenges
    • Limitation of holter recordings for arrhythmia monitoring

Porter's Five Forces: A Strategic Tool for Navigating the Arrhythmia Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Arrhythmia Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Arrhythmia Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Arrhythmia Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Arrhythmia Market

A detailed market share analysis in the Arrhythmia Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Arrhythmia Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Arrhythmia Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Arrhythmia Market

A strategic analysis of the Arrhythmia Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Arrhythmia Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, ACS Diagnostics, AliveCor, Inc., AtriCure Inc., Biotricity, BIOTRONIK, Inc., Boston Scientific Corporation, CardioFocus, Inc., CathRx Ltd., Fukuda Denshi, GE Healthcare, GlaxoSmithKline PLC, Hill-Rom Holdings, Inc, iRhythm Technologies Inc., Koninklijke Philips NV, Medi-Lynx Cardiac Monitoring, LLC, Medtronic PLC, MicroPort Scientific Corporation, Nihon Kohden Corporation, Novartis AG, OSI Systems, Inc., Sanofi S.A., SCHILLER, Siemens Healthcare GmbH, and St. Jude Medical, Inc..

Market Segmentation & Coverage

This research report categorizes the Arrhythmia Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Site Of Origin Atrial, market is studied across Atrial Tachycardia, Premature Atrial Contractions, Sinus Bradycardia, and Wandering Atrial Pacemaker.
  • Based on Test Equipment, market is studied across Electrocardiogram and Holter Monitor.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of arrhythmia among population and need for arrhythmia monitoring devices
      • 5.1.1.2. Trend of irrigated radiofrequency (RF) ablation catheter devices
      • 5.1.1.3. Rising awareness campaigns for arrhythmia
    • 5.1.2. Restraints
      • 5.1.2.1. High-cost associated with arrhythmia treatment and devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in arrhythmia devices
      • 5.1.3.2. Robust research activities to develop new arrhythmia treatments
    • 5.1.4. Challenges
      • 5.1.4.1. Limitation of holter recordings for arrhythmia monitoring
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Arrhythmia Market, by Site Of Origin Atrial

  • 6.1. Introduction
  • 6.2. Atrial Tachycardia
  • 6.3. Premature Atrial Contractions
  • 6.4. Sinus Bradycardia
  • 6.5. Wandering Atrial Pacemaker

7. Arrhythmia Market, by Test Equipment

  • 7.1. Introduction
  • 7.2. Electrocardiogram
  • 7.3. Holter Monitor

8. Americas Arrhythmia Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Arrhythmia Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Arrhythmia Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. ACS Diagnostics
  • 3. AliveCor, Inc.
  • 4. AtriCure Inc.
  • 5. Biotricity
  • 6. BIOTRONIK, Inc.
  • 7. Boston Scientific Corporation
  • 8. CardioFocus, Inc.
  • 9. CathRx Ltd.
  • 10. Fukuda Denshi
  • 11. GE Healthcare
  • 12. GlaxoSmithKline PLC
  • 13. Hill-Rom Holdings, Inc
  • 14. iRhythm Technologies Inc.
  • 15. Koninklijke Philips NV
  • 16. Medi-Lynx Cardiac Monitoring, LLC
  • 17. Medtronic PLC
  • 18. MicroPort Scientific Corporation
  • 19. Nihon Kohden Corporation
  • 20. Novartis AG
  • 21. OSI Systems, Inc.
  • 22. Sanofi S.A.
  • 23. SCHILLER
  • 24. Siemens Healthcare GmbH
  • 25. St. Jude Medical, Inc.

LIST OF FIGURES

  • FIGURE 1. ARRHYTHMIA MARKET RESEARCH PROCESS
  • FIGURE 2. ARRHYTHMIA MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ARRHYTHMIA MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ARRHYTHMIA MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ARRHYTHMIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS ARRHYTHMIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS ARRHYTHMIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES ARRHYTHMIA MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES ARRHYTHMIA MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC ARRHYTHMIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC ARRHYTHMIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ARRHYTHMIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ARRHYTHMIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ARRHYTHMIA MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. ARRHYTHMIA MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ARRHYTHMIA MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ARRHYTHMIA MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ARRHYTHMIA MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ARRHYTHMIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ARRHYTHMIA MARKET DYNAMICS
  • TABLE 7. GLOBAL ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ARRHYTHMIA MARKET SIZE, BY ATRIAL TACHYCARDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ARRHYTHMIA MARKET SIZE, BY PREMATURE ATRIAL CONTRACTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ARRHYTHMIA MARKET SIZE, BY SINUS BRADYCARDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ARRHYTHMIA MARKET SIZE, BY WANDERING ATRIAL PACEMAKER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ARRHYTHMIA MARKET SIZE, BY ELECTROCARDIOGRAM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ARRHYTHMIA MARKET SIZE, BY HOLTER MONITOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS ARRHYTHMIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES ARRHYTHMIA MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC ARRHYTHMIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA ARRHYTHMIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 101. ARRHYTHMIA MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 102. ARRHYTHMIA MARKET, FPNV POSITIONING MATRIX, 2023